Summary
Updated Aug 31, 2026
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is 10% Owner of NATURES SUNSHINE PRODUCTS INC (NATR). 2 SEC Form 4 filings on record, most recently on 17 October 2024. Most recent open-market trade: sold $30K of NATR on 17 October 2024. Lifetime open-market sales: $175K.
Recent Transactions
8Every recent SEC Form 4 transaction Shanghai Fosun Pharmaceutical (Group) Co., Ltd. has reported, most recent first.
Trading Pattern
InsiderAlpha's records for Shanghai Fosun Pharmaceutical (Group) Co., Ltd. go back to 2024: 2 primary Form 4 filings, an average of 0.7 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Shanghai Fosun Pharmaceutical (Group) Co., Ltd. files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. - $2.61M of NATR open-market activity in the last 12 months
- Bryant J. Yates - $913K of NATR open-market activity in the last 12 months
- Daniel C. Norman - $759K of NATR open-market activity in the last 12 months
- Nathan G. Brower - $341K of NATR open-market activity in the last 12 months
- Jonathan David Lanoy - $201K of NATR open-market activity in the last 12 months
- Kevin R. Herbert - $41K of NATR open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
What is Shanghai Fosun Pharmaceutical (Group) Co., Ltd.?
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is a corporate entity, tracked as 10% Owner of NATURES SUNSHINE PRODUCTS INC (NATR). InsiderAlpha holds 2 primary Form 4 filings for it, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Shanghai Fosun Pharmaceutical (Group) Co., Ltd. last file a Form 4?
The most recent primary Form 4 on record is dated 17 October 2024, one of 2 filings going back to 2024.
Has Shanghai Fosun Pharmaceutical (Group) Co., Ltd. been buying or selling stock?
Recorded transactions: 0 open-market purchases and 7 open-market sales ($175K) across all tracked filings.
Where can I see all of Shanghai Fosun Pharmaceutical (Group) Co., Ltd.'s SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Shanghai Fosun Pharmaceutical (Group) Co., Ltd. and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial